InspireMD Inc
XBER:II2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
U
|
Unilever PLC
XMUN:UNV0
|
UK |
|
FibroGen Inc
F:1FG0
|
US |
|
Tenable Holdings Inc
NASDAQ:TENB
|
US |
|
L
|
Laboratory Corporation of America Holdings
SWB:LAB
|
US |
|
L
|
Littelfuse Inc
SWB:LFS
|
US |
|
F
|
Flowserve Corp
XBER:FWV
|
US |
|
A
|
Asure Software Inc
SWB:VTE1
|
US |
|
R
|
Raymond James Financial Inc
F:RJF
|
US |
|
U
|
United Rentals Inc
XMUN:UR3
|
US |
|
Community Healthcare Trust Inc
F:4U9
|
US |
|
I
|
Italgas SpA
SWB:I10
|
IT |
|
Grupo Aeroportuario del Centro Norte SAB de CV
OTC:GAERF
|
MX |
Wall St Price Targets
II2 Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for
II2 is 25.826 EUR with a low forecast of 17.704 EUR and a high forecast of 36.811 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is II2's stock price target?
Price Target
25.826
EUR
According to Wall Street analysts, the average 1-year price target for
II2 is 25.826 EUR with a low forecast of 17.704 EUR and a high forecast of 36.811 EUR.
What is the Revenue forecast for InspireMD Inc?
Projected CAGR
76%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 2 years is 76%.